<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>{others} | Kaspar Rufibach, PhD</title>
    <link>https://www.kasparrufibach.ch/authors/others/</link>
      <atom:link href="https://www.kasparrufibach.ch/authors/others/index.xml" rel="self" type="application/rss+xml" />
    <description>{others}</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><lastBuildDate>Sun, 01 Jan 2017 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://www.kasparrufibach.ch/img/icon-192.png</url>
      <title>{others}</title>
      <link>https://www.kasparrufibach.ch/authors/others/</link>
    </image>
    
    <item>
      <title>Obinutuzumab for the first-line treatment of follicular lymphoma</title>
      <link>https://www.kasparrufibach.ch/publication/2017-01-01_obinutuzumab_for_the/</link>
      <pubDate>Sun, 01 Jan 2017 00:00:00 +0000</pubDate>
      <guid>https://www.kasparrufibach.ch/publication/2017-01-01_obinutuzumab_for_the/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Intracoronary injection of bone marrow--derived mononuclear cells early or late after acute myocardial infarction: Effects on global left ventricular function</title>
      <link>https://www.kasparrufibach.ch/publication/2013-01-01_intracoronary_inject/</link>
      <pubDate>Tue, 01 Jan 2013 00:00:00 +0000</pubDate>
      <guid>https://www.kasparrufibach.ch/publication/2013-01-01_intracoronary_inject/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry</title>
      <link>https://www.kasparrufibach.ch/publication/2013-01-01_predictors_for_effic/</link>
      <pubDate>Tue, 01 Jan 2013 00:00:00 +0000</pubDate>
      <guid>https://www.kasparrufibach.ch/publication/2013-01-01_predictors_for_effic/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI)</title>
      <link>https://www.kasparrufibach.ch/publication/2010-01-01_cell-based_therapy_f/</link>
      <pubDate>Fri, 01 Jan 2010 00:00:00 +0000</pubDate>
      <guid>https://www.kasparrufibach.ch/publication/2010-01-01_cell-based_therapy_f/</guid>
      <description></description>
    </item>
    
    <item>
      <title>logcondens: Computations related to univariate log-concave density estimation</title>
      <link>https://www.kasparrufibach.ch/publication/2010-01-01_logcondens_computati/</link>
      <pubDate>Fri, 01 Jan 2010 00:00:00 +0000</pubDate>
      <guid>https://www.kasparrufibach.ch/publication/2010-01-01_logcondens_computati/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Maximum likelihood estimation of a log-concave density and its distribution function: Basic properties and uniform consistency</title>
      <link>https://www.kasparrufibach.ch/publication/2009-01-01_maximum_likelihood_e/</link>
      <pubDate>Thu, 01 Jan 2009 00:00:00 +0000</pubDate>
      <guid>https://www.kasparrufibach.ch/publication/2009-01-01_maximum_likelihood_e/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer&#39;s disease</title>
      <link>https://www.kasparrufibach.ch/publication/2009-01-01_neuroprotective_natu/</link>
      <pubDate>Thu, 01 Jan 2009 00:00:00 +0000</pubDate>
      <guid>https://www.kasparrufibach.ch/publication/2009-01-01_neuroprotective_natu/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK)</title>
      <link>https://www.kasparrufibach.ch/publication/2005-01-01_single_agent_rituxim/</link>
      <pubDate>Sat, 01 Jan 2005 00:00:00 +0000</pubDate>
      <guid>https://www.kasparrufibach.ch/publication/2005-01-01_single_agent_rituxim/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy</title>
      <link>https://www.kasparrufibach.ch/publication/2004-01-01_concomitant_cisplati/</link>
      <pubDate>Thu, 01 Jan 2004 00:00:00 +0000</pubDate>
      <guid>https://www.kasparrufibach.ch/publication/2004-01-01_concomitant_cisplati/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
